Biomarkers in Inflammatory and Noninflammatory Cardiomyopathy (Q56986068)

https://api.crossref.org/works/10.1007/S00059-009-3318-2

A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Parvovirus B19 infection mimicking acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Predictors of outcome in patients with suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. A status report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

[Classification of cardiomyopathies and indication for endomyocardial biopsy revisited].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Cytotoxic perforin and TIA-1 infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Induction of major histocompatibility complex antigens within the myocardium of patients with active myocarditis: a nonhistologic marker of myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Inflammatory cardiomyopathy (myocarditis): which patients should be treated with anti-inflammatory therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Treatment of chronic myocarditis with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Viral persistence in the myocardium is associated with progressive cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

NS1 specific CD8 T-cells with effector function and TRBV11 dominance in a patient with parvovirus B19 associated inflammatory cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Role of virus-induced myocardial affections in sudden infant death syndrome: a prospective postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Cardiovascular magnetic resonance in myocarditis: A JACC White Paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Images in cardiovascular medicine. Parvovirus-B19-associated active myocarditis with biventricular thrombi. Results of endomyocardial biopsy investigations and cardiac magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis--a CMR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Electrocardiographic and cardiac magnetic resonance imaging parameters as predictors of a worse outcome in patients with idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Integrated biomarkers in cardiomyopathies: cardiovascular magnetic resonance imaging combined with molecular and immunologic markers--a stepwise approach for diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Biomarkers in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Long-term outcome of acute myocarditis is independent of cardiac enzyme release

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

The endotoxin-lipoprotein hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00059-009-3318-2

Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results

21 January 2018

1 reference

12 December 2020

Interobserver variability in the pathologic interpretation of endomyocardial biopsy results

1 reference

12 December 2020

Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy

1 reference

12 December 2020

Prevalence of the parvovirus B19 genome in endomyocardial biopsy specimens

1 reference

12 December 2020

Myocarditis--cardiomyopathy. Consensus Report of the German Association for Internal Medicine, presented at the 100th annual meeting, Wiesbaden, 13 April 1994.

1 reference

12 December 2020

Cardiac Troponin T in Patients With Clinically Suspected Myocarditis

1 reference

12 December 2020

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

12 December 2020

Parvovirus B19 profiles in patients presenting with acute myocarditis and chronic dilated cardiomyopathy.

1 reference

12 December 2020

Digital image analysis system for the quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy.

1 reference

12 December 2020

Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error

1 reference

12 December 2020

The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology

1 reference

12 December 2020

Contrast Media–Enhanced Magnetic Resonance Imaging Visualizes Myocardial Changes in the Course of Viral Myocarditis

1 reference

12 December 2020

Late persistent expressions of ICAM-1 and VCAM-1 on myocardial tissue in children with lymphocytic myocarditis

1 reference

12 December 2020

Benchmarks for the assessment of novel cardiovascular biomarkers

1 reference

12 December 2020

Immunohistological detection of Parvovirus B19 capsid proteins in endomyocardial biopsies from dilated cardiomyopathy patients

1 reference

12 December 2020

Meta-analysis of the association of enteroviruses with human heart disease

1 reference

12 December 2020

Low troponin-I levels on admission are associated with worse prognosis in patients with fulminant myocarditis

1 reference

12 December 2020

Parvovirus B19: a pathogen responsible for more than hematologic disorders

1 reference

12 December 2020

Myocarditis and endomyocardial biopsy

1 reference

12 December 2020

Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease

1 reference

12 December 2020

Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis

1 reference

12 December 2020

Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy

1 reference

12 December 2020

Myocarditis: the Dallas criteria

1 reference

12 December 2020